Memory disorders Flashcards
1
Q
What is amnesia
A
- drug induced - alcohol!
- head trauma - temporary or permanent
- retrograde or anterograde
- retrograde- erase stored memories
- anterograde- can’t make new memories
2
Q
What is dementia
A
- “A syndrome characterized by a decline in cognitive functions sufficient to cause impairment in social and occupational performance”
- Loss of multiple memory categories
- Inability to form new memories (learning)
- Associated with general cognitive decline
- memory impairment first presenting symptom
3
Q
What is Alzheimer’s disease
A
- Alois Alzheimer - 1907
- Most common dementia at >65 yrs
- 2:1 female:male
- memory deficits - presenting symptom
- Initiation deficits
- Visuo-spatial deficits
- Language deficits - word finding - comprehension - paraphasia
- Impaired judgment and executive functions - risk assessment
- Psychotic episodes
4
Q
What is the gross pathology of Alzheimer’s
A
- Early shrinkage - temporal poles, frontal cortex
- Earliest damage in entorhinal cortex - memory and speech defects
- progressive spread to whole cortex and subcortical structures
5
Q
What are some Diagnostic hallmarks of Alzheimer’s
A
- Neuritic plaques (NP) - extracellular - amyloid-beta-protein
- End up clumping into plaques extracellulary surrounding neurons
- Neurofribrillary tangles (NFT) - intracellular - abnormal cytoskeletal protein Tau
- Plaques can introduce intracellular tangles
- Together they cause neurodegeneration of neurons
- Primarily affect glutamate and acetylcholine neurones and terminals
- Aberrant function - synapse loss - neuronal death - brain shrinkage
6
Q
What is APP
A
- Every neuron has APP
- Amyloid precursor protein (APP) is an integral membrane protein expressed in many tissues and concentrated in the synapses of neurons.
- Its primary function is not known, though it has been implicated as a regulator of synapse formation, synaptic plasticity and iron export.
7
Q
How is APP normally cleaved
A
- Normally APP is cleaved by alpha-secretase to form two different peptides one of which is soluble - APPalpha which is extracellular
- Has trophic effects -Trophic generally nourishing or stimulatory – POSITIVE EFFECTS
- If not present brains don’t function
- What is left in membrane is cleaved by gamma-secretase
8
Q
How is APP cleaved abnormally
A
- Beta secretase cleaves APP instead of alpha
- Cleaves in different part
- When gamma cleaves what is left
- Beta amyloid is produced
- Causes beta amyloid plaques
- Enhanced by apoE4
- Thought that formation of plaque activates intracellular kinases
- Causes hyperphosphorylation of tau
- Tau when hyperphosphorylated clumps together to form tangles
9
Q
What are causes of AD
A
- ABETA40/42 not normally produced
- 90 % of AD cases are sporadic- not sure how happens
- Beta-secretase may be enhanced - environmental, disease, inflammation
- Genetic mutations identified in early onset AD (<65 years)
- In presenilin genes - excess beta-secretase activity – make more Abeta42 which is MOST likely to form plaques
- Genetic risk factor in late onset
- ApoE4 mutations - increased aggregation
10
Q
What causes memory loss
A
- Memory loss - loss of neurones and their connections
- Probably not direct impairment of memory mechanisms (LTP)
- But - Abeta40/42 MAY block LTP
11
Q
What is possible basis of neuronal death
A
- Plaques and metal ions (Cu + Fe) react to form H2O2
- This peroxidates membrane lipids
- React with reactive oxygen species and disrupt their function -disrupt function of receptors
- Excess Ca accumulation cell damage and death- caused by glutamate receptor disruption and Ca channel
- Causes death by excitotoxicity – stroke lecture
- Amyloid plaques hyperphosphorylated Tau which forms tangles which disrupts microtubular transport so more disruption of receptors and channels etc
- Ca accumulation thought to phosphorylate tau even more
12
Q
How do we treat Alzheimer’s – A symptomatic
A
- Cholinesterase inhibitors - cholinergic neurons damaged early in Alzheimer’s- first neurons to die-
disease - Memantine
- Nootropics (general cognitive enhancers)- Nothing effective yet….
13
Q
How do cholinesterase inhibitor help treat AD
A
- Inhibit cholinesterase increases acetylcholine
- donepezil, rivastigmine, galantamine
- enhance ACh at nicotinic and muscarinic receptors
- small improvements in cognition
- not on progression- don’t stop progression of
14
Q
How does memantine help treat AD
A
- non-competitive NMDA receptor blocker
- Neuroprotective?
- slight improvements in cognition
15
Q
How do we treat Alzheimer’s? B. disease progression
A
- Secretase inhibitors - in trials
- Anti-amyloid-beta vaccine / monoclonal antibodies – in trials
- Anti-tau vaccine / monoclonal antibodies – in trials- just recognizes hyperphosphorylated tau
- Copper and zinc chelators - metal ions promote plaque formation – toxic
- Growth factors - not feasible for routine therapy
- Antioxidants – limited evidence – eg. Vitamin C, flavinoids
- Statins – some epidemiological evidence- cholesterol promotes amyloid deposition
- biomarkers- for early diagnosis - very expensive- to do brain scans
- blood test- would be ideal